1. Home
  2. CHSCO vs ZLAB Comparison

CHSCO vs ZLAB Comparison

Compare CHSCO & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CHS Inc. Class B Cumulative Redeemable Preferred Stock

CHSCO

CHS Inc. Class B Cumulative Redeemable Preferred Stock

HOLD

Current Price

$26.08

Market Cap

0.0

Sector

Industrials

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$19.04

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHSCO
ZLAB
Founded
N/A
2013
Country
United States
China
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.0B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
CHSCO
ZLAB
Price
$26.08
$19.04
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$57.22
AVG Volume (30 Days)
N/A
832.3K
Earning Date
N/A
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$441,629,000.00
Revenue This Year
N/A
$26.16
Revenue Next Year
N/A
$30.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.14
52 Week Low
N/A
$16.82
52 Week High
N/A
$44.34

Technical Indicators

Market Signals
Indicator
CHSCO
ZLAB
Relative Strength Index (RSI) 59.02 52.19
Support Level $26.02 $17.18
Resistance Level $26.29 $17.97
Average True Range (ATR) 0.16 0.61
MACD 0.05 0.34
Stochastic Oscillator 98.25 87.27

Price Performance

Historical Comparison
CHSCO
ZLAB

About CHSCO CHS Inc. Class B Cumulative Redeemable Preferred Stock

CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Share on Social Networks: